| 상품명칭 |
노르-비날토르피민 디하이드로클로라이드 |
| 별명 |
노르비날토르피민; 노르-비날토르피민; 노르-브니; 4,8:11,15-Dimethano-20H-bisbenzofuro(2,3-a:3',2'-i)dipyrido(4,3-b:3',4'-h)카르바졸-1,8a,10a,18-테트롤, 7,12-비스(시클로프로필메틸)-5,6,7,8,9,10,11,12,13,14,19a,20b-도데카하이드로-, (4bS,8R,8aS,10aS,11R,14aS,19aR,20bR)-; 4,8:11,15-Dimethano-20H-비스벤조푸로(2,3-a:3',2'-i)디피리도(4,3-b:3',4'-h)카르바졸-1,8a,10a,18-테트롤, 7,12-비스(시클로프로필메틸)-5,6,7,8,9,10,11,12,13,14,19a,20b-도데카하이드로-20-메틸-, (8R-(4bR*,8alpha,8abeta,10aalpha,11beta,14aR*,19aalpha,20bbeta))-; 5,16- 디 시클로 프로필 -4,5,7,8,10,11,13,14,16,17,22,22b- 도데 카 하이드로 -21aH-6,9 : 12,15- 디메 탄 노비 사조 치노 [4 ', 5', 6': 3,4] [1] 벤조 푸로 [2,3-A : 3', 2'-i] 카르 바졸 -1,9,12,20- 테트롤 |
| 영문 이름 |
nor-binaltorphimine dihydrochloride;Norbinaltorphimine; Nor-binaltorphimine; Nor-bni; 4,8:11,15-Dimethano-20H-bisbenzofuro(2,3-a:3',2'-i)dipyrido(4,3-b:3',4'-h)carbazole-1,8a,10a,18-tetrol, 7,12-bis(cyclopropylmethyl)-5,6,7,8,9,10,11,12,13,14,19a,20b-dodecahydro-, (4bS,8R,8aS,10aS,11R,14aS,19aR,20bR)-; 4,8:11,15-Dimethano-20H-bisbenzofuro(2,3-a:3',2'-i)dipyrido(4,3-b:3',4'-h)carbazole-1,8a,10a,18-tetrol, 7,12-bis(cyclopropylmethyl)-5,6,7,8,9,10,11,12,13,14,19a,20b-dodecahydro-20-methyl-, (8R-(4bR*,8alpha,8abeta,10aalpha,11beta,14aR*,19aalpha,20bbeta))-; 5,16-dicyclopropyl-4,5,7,8,10,11,13,14,16,17,22,22b-dodecahydro-21aH-6,9:12,15-dimethanobisazocino[4',5',6':3,4][1]benzofuro[2,3-a:3',2'-i]carbazole-1,9,12,20-tetrol |
| 분자식 |
C40H43N3O6 |
| 분자량 |
661.7859 |
| InChI |
InChI=1/C40H43N3O6/c44-27-7-5-21-13-25(19-1-2-19)42-11-9-39-29(21)33(27)48-35(39)31-23(15-37(39,46)17-42)24-16-38(47)18-43-12-10-40(38)30-22(14-26(43)20-3-4-20)6-8-28(45)34(30)49-36(40)32(24)41-31/h5-8,19-20,25-26,35-36,41,44-47H,1-4,9-18H2 |
| cas번호 |
105618-26-6 |
| 분자 구조 |
|
| 밀도 |
1.63g/cm3 |
| 굴절 지수 |
1.834 |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
KR
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
MY
NL
NO
PL
PT
RU
SA
TR
